Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
STAT3 is crucial for maintaining pericyte homeostasis
Read the latest publication…
Mosaic loss of Y chromosome and mortality after coronary angiography
New paper about the loss of Y chromosome…
Find out how targeting mir92a or its downstream effectors may hold therapeutic potential in HFpEF
Read our latest paper…
NEWS: Awards & Grants
Poster Prize for Mariana Shumliakivska at the ISHR World Congress
Mariana Shumliakivska has been awarded the ISHR Poster Prize…
Young Investigator Award for Julian Wagner
Julian Wagner was awarded with the Young Investigator Award at the PCVB Meeting 2025…
Poster Prize for Colin Bodemer
Colin Bodemer wins Poster Prize at the PCVB Meeting 2025…